StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
— · INMB·Healthcare

INMB Stock Analysis & AI Score

INMB (INMB) has an ST Score of 43.6 (C), driven by its Forecast (A) and held back by its Profitability (D). INMB last traded at $2.00.

Market Closed
$2.00
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
44
ST Score
43.6/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
Exchange—

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

INMB
43.6out of 100
Grade C

INMB (INMB) has an ST Score of 43.6 (C), driven by its Forecast (A) and held back by its Profitability (D). INMB last traded at $2.00.

Strongest
ForecastA
Weakest
ProfitabilityD
All factor grades
  • ForecastA
  • ValuationB+
  • MomentumB+
  • GrowthC-
  • Financial StrengthD+
  • ProfitabilityD
  • Piotroski1/9
Score methodology
Press Releases

Contact

INMB stock: frequently asked questions

What is INMB's ST Score?

INMB (INMB) has an ST Score of 43.6 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is INMB a buy, hold, or sell?

Our ST Score grades it C (43.6/100). The ST Score is a data-driven signal, not a recommendation.

What are INMB's factor grades?

Valuation B+, Profitability D, Financial Strength D+, Momentum B+, Growth C-, Forecast A.

What is INMB's valuation grade?

INMB (INMB) earns a valuation grade of B+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is INMB's growth grade?

INMB (INMB) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is INMB's profitability grade?

INMB (INMB) earns a profitability grade of D, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is INMB's financial strength grade?

INMB (INMB) earns a financial strength grade of D+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is INMB's Piotroski score?

INMB (INMB) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.